Uncategorized

XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise

XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise

Published

on

Plus, news about PCI Pharma:

🏭 XTL Bio steps into psychedelics: XTL Biopharmaceuticals is acquiring 100% of the outstanding shares of psychedelic-focused biotech Psyga Bio. XTL will gain Psyga’s manufacturing facility …​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version